reports
- Konrad Zomer
- Thomas Zlowodzki
LHA DEUTSCHE LUFTHANSA AG
MT ARCELORMITTAL SA
GALP GALP ENERGIA SGPS SA CLASS B
DBK DEUTSCHE BANK AG
FORTUM FORTUM OYJ
DAI DAIMLER AG
RXL REXEL SA
TEP TELEPERFORMANCE SE
WKL WOLTERS KLUWER NV
REE RED ELECTRICA CORP. SA
ORSTED ORSTED
GN GN STORE NORD A/S
VOW3 VOLKSWAGEN AG PREF
CAP CAPGEMINI SE
NEM NEMETSCHEK SE
RAA RATIONAL AG
AENA AENA SME SA
CABK CAIXABANK SA
WLN WORLDLINE SA
INGA ING GROEP NV
BBVA BANCO BILBAO VIZCAYA ARGENTARIA S.A.
STLA STELLANTIS N.V.
SHEL SHELL PLC
GSK GSK PLC
DSFIR KONINKLIJKE DSM N.V.
NOVO B NOVO NORDISK A/S
- Konrad Zomer
- Thomas Zlowodzki
ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 05/02/2024
We are removing GALP from our ODDO BHF European Large Caps list. The stock has chalked up a performance of +31.3% since its inclusion in the list on 20 March. Our analyst is adopting today a Neutral recommendation (vs Outperform) on the stock. - ...
LHA DEUTSCHE LUFTHANSA AG
MT ARCELORMITTAL SA
GALP GALP ENERGIA SGPS SA CLASS B
DBK DEUTSCHE BANK AG
FORTUM FORTUM OYJ
DAI DAIMLER AG
RXL REXEL SA
TEP TELEPERFORMANCE SE
WKL WOLTERS KLUWER NV
REE RED ELECTRICA CORP. SA
ORSTED ORSTED
GN GN STORE NORD A/S
VOW3 VOLKSWAGEN AG PREF
CAP CAPGEMINI SE
NEM NEMETSCHEK SE
RAA RATIONAL AG
AENA AENA SME SA
CABK CAIXABANK SA
WLN WORLDLINE SA
INGA ING GROEP NV
BBVA BANCO BILBAO VIZCAYA ARGENTARIA S.A.
STLA STELLANTIS N.V.
SHEL SHELL PLC
GSK GSK PLC
DSFIR KONINKLIJKE DSM N.V.
NOVO B NOVO NORDISK A/S
- Konrad Zomer
Wolters Kluwer : Q1 trading update confirms the ongoing strong operati...
>Ongoing strong operational performance, both margins and FCF up yoy - With Euronext closed today because of Labour day, there is no rush to absorb the content of Wolters Kluwer’s Q1 trading update. It reads well and reflects an ongoing solid operational performance. Organic revenue growth in Q1 was 6% (FY 2023: 6%) with recurring revenue growth 7%, expert solutions up 8% organically (now 59% of the group) and cloud software revenues up 16% (2023: +15%). In Q1, both t...
- Guy Sips
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Michiel Declercq
- Sharad Kumar S.P
- Thibault Leneeuw
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Wim Lewi
Dynamic Top Pick List Update May 2024 : Adding Fugro, Removing Arcadis
In this May edition of our Dynamic Top Pick List we replace Arcadis by Fugro. Arcadis continues to deliver consistently on its promises and is working hard to realise its 2026 margin targets via cross selling, leveraging its global engineering platform and numerous self-help measures. In spite of this we remove Arcadis from our Dynamic Top Pick List as the recent & strong share price performance leaves little room for further short term triggers As a service provider to the energy industry, Fu...
BEKB BEKAERT SA
ABN ABN AMRO BANK NV DEPOSITARY RECEIPTS
EVS EVS BROADCAST EQUIPMENT SA
SOLB SOLVAY SA
DIE D'IETEREN SA
SOF SOFINA SA
GIMB GIMV NV
VAN VAN DE VELDE S.A.
IBAB ION BEAM APPLICATIONS SA
ACKB ACKERMANS & VAN HAAREN NV
ARCAD ARCADIS NV
TUB FINANCIERE DE TUBIZE S.A.
CPINV CARE PROPERTY INVEST SA
TWEKA TKH GROUP N.V. CERT
TINC TINC COMM. VA
FUR FUGRO NV
SHUR SHURGARD SELF STORAGE LIMITED
SYENS SYENSQO
- David Vagman
- CFA
- Marc Hesselink
- CFA
- Thymen Rundberg
Wolters Kluwer/Good start to the year/BUY
Wolters Kluwer reported a 1Q24 trading update slightly ahead of our expectations. Overall organic revenue growth was inline with our estimates, and we see strong performance across the company's largest divisions Health and Tax & Accounting offset slightly lower-than-expected growth in Corporate Performance & ESG. We make minor adjustments to our estimates and keep our BUY and €170 target price.
- Thomas Couvreur
Wolters Kluwer FIRST LOOK: Solid 1Q24 update; FY24 guidance reiterated
Wolters Kluwer reported a limit trading update highlighting some top line figures. WKL has a good start to the year despite some challenging environments and difficult comparables in some segments. FY24 guidance provided last quarter has been reiterated today. If WKL continues this strong growth trajectory, supported by solid margins, we believe our estimate are likely to end up too conservatively.
Wolters Kluwer First-Quarter 2024 Trading Update
Wolters Kluwer First-Quarter 2024 Trading Update Wolters Kluwer First-Quarter 2024 Trading Update Alphen aan den Rijn, May 1, 2024 – Wolters Kluwer, a global leader in professional information, software solutions and services, today releases its first-quarter 2024 trading update. Highlights Full-year 2024 guidance reiterated.First-quarter revenues up 6% in constant currencies and up 6% organically. Recurring revenues (82%) up 7% organically; non-recurring revenues up 1% organically.Expert solutions revenues (59%) up 8% organically.Cloud software revenues (18%) up 16% organically. ...
Share Buyback Transaction Details April 25 – April 29, 2024
Share Buyback Transaction Details April 25 – April 29, 2024 Share Buyback Transaction Details April 25 – April 29, 2024 April 30, 2024 - Wolters Kluwer (Euronext: WKL), a global leading provider of expert solutions, insights and services for professionals, today reports that it has repurchased 100,546 of its own ordinary shares in the period from April 25, 2024, up to and including April 29, 2024, for 14.1 million and at an average share price of €140.32. The previously disclosed third-party agreement to repurchase shares for €205 million during the period starting February 23, 20...
BioSenic S.A. : Information on the total number of voting rights and ...
BioSenic S.A. : Information on the total number of voting rights and shares PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, April 30, 2024, 7.00 am CEST – (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, today announces an increase in the total number of voting rights and shares as a result of the issuance of new shares. The following information is published in accordance with Article 15 of the Belgian law of 2 May 2007 on the publication of major shareholdings in issuers...
Participation notification by UBS Group AG
Participation notification by UBS Group AG Brussels, April 29, 2024, 08:30 CEST - Regulated information In line with Belgian transparency legislation (Law of May 2, 2007), UBS Group AG recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 5%. The notification, dated April 23, 2024, contains the following information: Reason for the notification: acquisition or disposal of financial instruments that are treated as voting securities. Notified by: A parent undertaking or a controlling person Date on which the threshold is ...
Notification de participation par UBS Group AG
Notification de participation par UBS Group AG Bruxelles, le 29 avril 2024 - 08h30 CET - Information régulée Conformément à la législation et réglementation en matière de transparence financière (loi du 2 mai 2007), UBS Group AG a envoyé récemment à Solvay la notification de transparence suivante indiquant avoir franchi le seuil de 5%. La notification, datée du 23 avril 2024, contient l’information suivante: Motif de la notification: acquisition ou cession d’instruments financiers conférant le droit de vote. Notification par: une entreprise-mère ou une personne détenant l...
Participatiemelding van UBS Group AG
Participatiemelding van UBS Group AG Brussel, 29 april 2024 - 8u30 CET - Gereglementeerde informatie In overeenstemming met de Belgische transparantiewetgeving (Wet van 2 mei 2007) heeft UBS Group AG onlangs de volgende transparantiekennisgeving naar Solvay gestuurd om aan te geven dat ze de drempel van 5% heeft overschreden. De kennisgeving, gedateerd 23 april 2024, bevat de volgende informatie: Reden voor de kennisgeving: verwerving of overdracht van stemrechtverlenende effecten Kennisgeving door: een moederonderneming of een controlerende persoon Datum waarop de drempel ...
BioSenic publie sur son site web le plan de restructuration soumis au ...
BioSenic publie sur son site web le plan de restructuration soumis au tribunal des entreprises de Nivelles COMMUNIQUE DE PRESSE – INFORMATION PRIVILIGIEE Mont-Saint-Guibert, Belgique, le 26 avril 2024 à 17h30 CEST – (Euronext Bruxelles et Paris: BIOS), la société en phase clinique spécialisée dans les maladies auto-immunes et inflammatoires graves, dans le cadre du plan de restructuration global annoncé le 11 avril 2024, annonce aujourd'hui la publication sur son site internet de la documentation suivante : Le plan de restructuration couvrant les années 2024-2030 soumis au Tribunal...
BioSenic publishes on its website the restructuring plan submitted to ...
BioSenic publishes on its website the restructuring plan submitted to the Enterprise Court of Nivelles PRESS RELEASE - PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, 26 April 2024, 17:30 CET – (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases, as part of the global restructuring plan announced on 11 April 2024, today announces the publication on its website of the following documentation : The restructuring plan covering the years 2024-2030 submitted to the Enterprise Court of Nivelles – accessible via th...
Solvay publishes notice of 2024 Annual General Meeting
Solvay publishes notice of 2024 Annual General Meeting Brussels, April 26, 2024, 8:00am CEST - regulated information Solvay today published materials for its next Ordinary General Shareholders’ Meeting, which will be held on Tuesday May 28, 2024 at the Event Lounge Conference Center, Boulevard Général Wahis 16/F, 1030 Brussels, at 10.30 am CEST. All documents relating to this meeting are now available on . Shareholders will be asked to vote on a number of , among others: the approval of the financial statements for the financial year 2023; the approval of a total gross di...
Solvay publie la convocation à son Assemblée Générale annuelle de 2024
Solvay publie la convocation à son Assemblée Générale annuelle de 2024 Bruxelles, le 26 avril 2024 - 8h00 CEST - information réglementée Solvay annonce la publication des documents relatifs à sa prochaine Assemblée Générale Ordinaire, qui se tiendra le mardi 28 mai 2024 à 10h30 CEST à l’Event Lounge Conference Center situé Boulevard Général Wahis 16/F, 1030 Bruxelles. Tous les documents relatifs à cette assemblée sont désormais disponibles sur le de l’entreprise. Les actionnaires seront invités à voter sur un certain nombre de , parmi lesquelles: l’approbation des comptes annuels ...
Solvay publiceert oproep tot Algemene Vergadering van 2024
Solvay publiceert oproep tot Algemene Vergadering van 2024 Brussel, 26 april 2024 - 8u00 CEST - Gereglementeerde informatie Solvay heeft vandaag de documenten voor zijn volgende Gewone Algemene Vergadering gepubliceerd. Deze zal plaatsvinden op dinsdag 28 mei 2024 in het Event Lounge Conference Center, Generaal Wahislaan 16/F, 1030 Brussel, om 10.30 uur CEST. Alle documenten met betrekking tot deze vergadering zijn nu beschikbaar op . De aandeelhouders zullen worden gevraagd te stemmen over een aantal , waaronder: de goedkeuring van de jaarrekening voor het boekjaar 2023; de...
Share Buyback Transaction Details April 18 – April 24, 2024
Share Buyback Transaction Details April 18 – April 24, 2024 Share Buyback Transaction Details April 18 – April 24, 2024 April 25, 2024 - Wolters Kluwer (Euronext: WKL), a global leading provider of expert solutions, insights and services for professionals, today reports that it has repurchased 159,569 of its own ordinary shares in the period from April 18, 2024, up to and including April 24, 2024, for 22.6 million and at an average share price of €141.62. These repurchases are part of the share buyback program announced on February 21, 2024, under which we intend to repurchase shares...
- ING Helpdesk
Benelux Morning Notes
Azelis: Strong margin performance in weak trading results in 3% EBITA beat. BE Semiconductor Industries: 1Q24 results; prolonged downcycle. Coca-Cola Europacific Partners plc: Messy but good. DWS: Record breaking. Flow Traders: Crypto Kings. Fugro: Here we go again. Kinepolis: Weak start to the year, but a bit better than feared. UCB: Changes in the group executive committee. Unilever: Heading in the right direction. Vonovia: Disposal of 4,500 apartments for €700m. Wolters Kl...
BioSenic postpones its annual general meeting of the shareholders and ...
BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023 PRESS RELEASE - PRIVILEGED INFORMATION In view of the restructuring plan announced on April 11, 2024, BioSenic has decided to postpone the publication of its 2023 annual report as well as its annual general meeting of shareholders, so that the Enterprise Court of Nivelles can make a decision before the completion of the annual formalities. The Company believes that this postponement is preferable to ensure that the financial statements can be prepared on a going...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.